Xiu-li Guo-Li

Department Of Pharmacology Drug Screening Platform Of Shandong Province Center For Drug R&D
Jinan, 250012, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

GLS1 inhibitor CB-839 inhibits the malignant progression of 5-FU resistant hepatoma cells by regulating glutamine metabolism.

GLS1 inhibitor CB-839 inhibits the malignant progression of 5-FU resistant hepatoma cells by regulating glutamine metabolism.

Journal: Chemico-biological interactions

Published: August 18, 2025

Exosomal lncRNA MIR210HG derived from hypoxic TAMs promotes the metastasis of triple negative breast cancer.

Exosomal lncRNA MIR210HG derived from hypoxic TAMs promotes the metastasis of triple negative breast cancer.

Journal: International immunopharmacology

Published: May 21, 2025

MCP-enhanced SOD3 activity inhibits gastric cancer and potentiate chemotherapy via modulating EGFR signaling.

MCP-enhanced SOD3 activity inhibits gastric cancer and potentiate chemotherapy via modulating EGFR signaling.

Journal: Life sciences

Published: October 28, 2024

CYP2A6 suppresses hepatocellular carcinoma via inhibiting SRC/Wnt/β-Catenin pathway.

CYP2A6 suppresses hepatocellular carcinoma via inhibiting SRC/Wnt/β-Catenin pathway.

Journal: Acta pharmacologica Sinica

Published: July 19, 2024

Pharmacokinetic and bioequivalence study of two capecitabine tablets in Chinese patients with solid tumor cancer.

Pharmacokinetic and bioequivalence study of two capecitabine tablets in Chinese patients with solid tumor cancer.

Journal: Cancer chemotherapy and pharmacology

Published: October 20, 2023

Metabolic reprogramming of glutamine involved in tumorigenesis, multidrug resistance and tumor immunity.

Metabolic reprogramming of glutamine involved in tumorigenesis, multidrug resistance and tumor immunity.

Journal: European journal of pharmacology

Published: May 31, 2022

Pantoprazole ameliorates liver fibrosis and suppresses hepatic stellate cell activation in bile duct ligation rats by promoting YAP degradation.

Pantoprazole ameliorates liver fibrosis and suppresses hepatic stellate cell activation in bile duct ligation rats by promoting YAP degradation.

Journal: Acta pharmacologica Sinica

Published: April 11, 2021

Targeting galectins in T cell-based immunotherapy within tumor microenvironment.

Targeting galectins in T cell-based immunotherapy within tumor microenvironment.

Journal: Life sciences

Published: February 10, 2021

Modified citrus pectin inhibits breast cancer development in mice by targeting tumor-associated macrophage survival and polarization in hypoxic microenvironment.

Modified citrus pectin inhibits breast cancer development in mice by targeting tumor-associated macrophage survival and polarization in hypoxic microenvironment.

Journal: Acta pharmacologica Sinica

Published: January 25, 2021

Design and screening of a novel neuropilin-1 targeted penetrating peptide for anti-angiogenic therapy in glioma.

Design and screening of a novel neuropilin-1 targeted penetrating peptide for anti-angiogenic therapy in glioma.

Journal: Life sciences

Published: September 13, 2020

Galectin-3 expression and secretion by tumor-associated macrophages in hypoxia promotes breast cancer progression.

Galectin-3 expression and secretion by tumor-associated macrophages in hypoxia promotes breast cancer progression.

Journal: Biochemical pharmacology

Published: April 19, 2020

New insights into molecular chaperone TRAP1 as a feasible target for future cancer treatments.

New insights into molecular chaperone TRAP1 as a feasible target for future cancer treatments.

Journal: Life sciences

Published: February 29, 2020

Showing 1-12 of 29

Last Updated: 09/26/2026